CROI 2016 Program at a Glance

Program and Agenda

1001 Reliance on RyanWhite Coverage for Provider Visits Following the Affordable Care Act Stephen A. Berry 1 ; John Fleishman 2 ; Baligh R.Yehia 3 ; Richard Moore 1 ; Allison L. Agwu 1 ;Wm. Christopher Mathews 4 ;Todd Korthuis 5 ; Ank E. Nijhawan 6 ; Kelly A. Gebo 1 ; for the HIV Research Network 1 JohnsHopkinsUniv,Baltimore,MD,USA; 2 Agency forHlthcareRsrand Quality,Rockville,MD,USA; 3 UnivofPennsylvania,Philadelphia,PA, USA; 4 UnivofCaliforniaSanDiego,SanDiego,CA,USA; 5 OregonHlth &SciUniv,Portland,OR,USA; 6 UnivofTexasSouthwesternMedCntr, Dallas,TX,USA 1002 Receipt of RyanWhite Care Services Is AssociatedWith Improved Long-Term Outcomes Tanner Nassau ; Melissa Miller; ColemanTerrell; Sebastian Branca; Kathleen Brady PhiladelphiaDeptofPH,Philadelphia,PA,USA 1003 The Causal Impact of ART Initiation on Household Food Security Bryan N. Patenaude 1 ; Natsayi Chimbindi 2 ; Deenan Pillay 2 ;Till Bärnighausen 1 1 HarvardSchofPH,Boston,MA,USA; 2 AfricaCntr forHlthandPop Studies,Mtubatuba,SouthAfrica 2:45 PM-4:00 PM Going to ScaleWith ART and PrEP 1048 Effect of Eliminating CD4 Thresholds on Number of New ART initiators in South Africa Jacob Bor 1 ; Shahira Ahmed 2 ; Matthew P. Fox 2 ; Sydney Rosen 2 ; Frank Tanser 3 ; Deenan Pillay 3 ;Till Bärnighausen 4 1 BostonUnivSchofPH,Boston,MA,USA; 2 BostonUniv,Boston,MA,USA; 3 AfricaCntr forHlthandPopStudies,Mtubatuba,SouthAfrica; 4 Harvard SchofPH,Boston,MA,USA 1049 Optimizing Resource Allocation to Reduce HIV Incidence Across Sub-Saharan Africa Jessica McGillen ; Sarah-Jane Anderson;Timothy Hallett ImperialCollLondon,London,UK 1050 New ARVs Could Represent Over USD 3 Billion in Cost Savings Through 2025 Vineet R. Prabhu , Clinton Hlth Access Initiative, Boston,MA,USA 1051 Impact of Improving HIV Care and Treatment and Initiating PrEP in the United States, 2015-2020 EmineYaylali 1 ; Paul Farnham 1 ; Evin Jacobson 1 ; BenjaminT. Allaire 2 ; Danielle L.Wagner 3 ; Katherine A. Hicks 4 ; Amanda A. Honeycutt 2 ; Stephanie L. Sansom 1 1 CDC,Atlanta,GA,USA; 2 RTI,ResearchTrianglePark,NC,USA; 3 RTI, Waltham,MA,USA; 4 RTIHlthSolutions,ResearchTrianglePark,NC,USA 1052 PrEP Is Only Cost-Effective Among MSM in the Netherlands When Used on Demand Brooke E. Nichols 1 ; Charles A. Boucher 1 ; Marc van derValk 2 ; Bart J. Rijnders 1 ; David A. van deVijver 1 1 ErasmusUnivMedCntr,Rotterdam,Netherlands; 2 AcademicMedCntr, Amsterdam,Netherlands Session P-Y2 Poster Abstracts Hall D

Session P-Y3 Poster Abstracts

Hall D

2:45 PM-4:00 PM Modeling the (Cost) Efficiency of Testing and Prevention 1053 Linkage of UK HIV and Tuberculosis Data Using Probabilistic and Deterministic Methods Joanne R.Winter 1 ;Valerie Delpech 2 ; Peter Kirwan 2 ; Helen R. Stagg 1 ; SrividhyaVenugopalan 2 ; Andrew Skingsley 2 ; Maeve K. Lalor 2 ; H. L. Thomas 2 ; Ibrahim R. Abubakar 1 1 UnivCollLondon,London,UK; 2 PHEngland,London,UK 1054 Optimal Rollout of“Treatment As Prevention”in Africa: Efficiency Versus Equity Brian J. Coburn; Justin Okano ; Sally Blower UnivofCaliforniaLosAngeles,LosAngeles,CA,USA 1055 Modeled Effectiveness of Nondaily PrEP Based on Sex Coverage Data FromHPTN067 ADAPT DobromirT. Dimitrov 1 ; Kate M. Mitchell 2 ; James P. Hughes 3 ; Deborah Donnell 1 ; Linda-Gail Bekker 4 ; Robert Grant 5 ; Marie-Claude Boily 2 1 FredHutchinsonCancerRsrCntr,Seattle,WA,USA; 2 ImperialColl London,London,UK; 3 UnivofWashington,Seattle,WA,USA; 4 Desmond TutuHIVCntr,CapeTown,SouthAfrica; 5 UnivofCaliforniaSanFrancisco, SanFrancisco,CA,USA 1056 Scale-up of Antiretroviral Therapy and Preexposure Prophylaxis in Swaziland EugeneT. Richardson 1 ; Futhi Dennis 2 ; Nokwazi Mathabela 2 ; Khanya Mabuza 2 ; AllenWaligo 2 ; Eran Bendavid 1 ; Sabina Alistar 1 ; Marelize Gorgens 3 ; FrancoisVenter 4 1 StanfordUniv,Stanford,CA,USA; 2 NatlEmergencyResponseCouncil onHIVandAIDS (NERCHA),Mbabane,Swaziland; 3 TheWorld Bank,Washington,DC,USA; 4 WitsReproductiveHlthandHIV Inst, Johannesburg,SouthAfrica 1057 Dapivirine Vaginal Ring Preexposure Prophylaxis for HIV Prevention in South Africa Robert Glaubius 1 ; Kerri J. Penrose 2 ; Greg Hood 3 ; Urvi M. Parikh 2 ; Ume Abbas 4 1 ClevelandClinic,Cleveland,OH,USA; 2 UnivofPittsburgh,Pittsburgh,PA, USA; 3 PittsburghSupercomputingCntr,Pittsburgh,PA,USA; 4 BaylorColl ofMed,Houston,TX,USA 1058 Cost-Effectiveness of the Intravaginal Dapivirine Ring: A Modeling Analysis Jennifer Smith 1 ; Kate Harris 2 ; Geoff Garnett 2 ; LutVan Damme 2 ; Timothy Hallett 1 1 ImperialCollLondon,London,UK; 2 BillandMelindaGatesFndn,Seattle, WA,USA 1059 Determinants of Economic Efficiency in HIV Prevention: Evidence From ORPHEA Kenya Omar Galarraga 1 ; RichardWamai 2 ; Sandra G. Sosa-Rubi 3 ; Mercy Mugo 4 ; David Contreras 3 ; Sergio Bautista-Arredondo 3 ; Helen Nyakundi 4 ; JosephWang’Ombe 4 1 BrownUnivSchofPH,Providence,RI,USA; 2 NortheasternUniv,Boston, MA,USA; 3 INSP,Cuernavaca,Mexico; 4 UnivofNairobi,Nairobi,Kenya

Poster Listings

CROI 2016 103